Technical Analysis: PODD is currently trading at $280.70, showing a mixed technical picture. The RSI-14 at 54.51 indicates neutral momentum, while the MACD (3.49) remains positive but shows weakening momentum with a negative histogram (-0.47).
Support and Resistance Levels:
Price Trend Analysis: The stock is trading above all major moving averages:
News Impact: Recent market sentiment remains neutral to slightly positive. According to recent analyst coverage, PODD has received Strong Buy ratings with a price target of $299.15, implying a 6.83% upside potential. The company's pre-tax income has shown impressive growth with a CAGR of 71.4% over the past five years.
Price Prediction for Next Week: Based on technical indicators and Fibonacci levels:
Trading Recommendation: BUY
Rationale:
The price of PODD is predicted to go up 3.46%, based on the high correlation periods with AVAL. The similarity of these two price pattern on the periods is 96.05%.
PODD
AVAL
We see global growth for the insulin pump market, as Type 1 diabetics embrace continuous subcutaneous insulin infusion therapy for its lower rate of long-term diabetes-related complications.
Insulet created the first (and still only) tubeless insulin pump on the U.S. market for the Type 1 market and has a head start on the manufacturing learning curves.
With makers of continuous glucose monitors focused on converting the much larger type 2 diabetes population, Insulet has benefited as some of these patients also opt to adopt an insulin pump.
TD Cowen
2025-01-03
Price Target
$264 → $324
Upside
+21.67%
Citigroup
2024-12-11
Price Target
$283 → $310
Upside
+13.36%
Canaccord Genuity
2024-12-09
Price Target
$269 → $304
Upside
+14.67%